Topic: Electrophysiological biomarkers

Cognitive functions, including memory, perception, learning, attention, language abilities, problem solving, and decision making, are impaired in a range of neurodegenerative, neurodevelopmental, and neuropsychiatric diseases. Current therapeutic options are limited to the pharmacological and behavioral therapies. Neuromodulation therapies that target specific neural activities and brain areas require robust electrophysiological biomarkers that indicate cognitive performance in clinically validated tests. To identify specific cortical areas and spectral activities that indicate behavioral diff